Project Grant K99HL179260
Award Date
7/15/25
Completion Date
6/30/27
Dollars Obligated
$121K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Cleveland, OH 44106, USA
Similar Awards
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $420,600 Project Grant under CFDA 93.837 - Cardiovascular Diseases Research to the University of Colorado-Denver. The grant's objective is to design elastic hydrogel microparticles as a platform to measure key elements of platelet function, including adhesion, activation, aggregation, and contraction. This innovative "lab-on-a-particle" approach aims to improve the reliability and reproducibility of platelet function...
This Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) will provide $730,764 to Case Western Reserve University to conduct research on the molecular basis of cardiac myosin binding protein C (cMyBP-C) variants and their impact on the development of hypertrophic cardiomyopathy (HCM). The primary goals are to: 1) determine the structural effects of cMyBP-C missense variants using cryo-electron microscopy, 2) elucidate the...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $573,261 to the University of Rochester to investigate the role of platelet-monocyte interactions in regulating immune responses and inflammation. The key aims are to determine: 1) the signaling mechanisms by which resting platelets "immune train" monocytes to a quiescent state, 2) the functional outcomes of this...
This $604,301 Project Grant awarded by the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) to Versiti Wisconsin, Inc. supports research on the role of the membrane-shaping protein PACSIN2 in regulating platelet production and function. The research aims to characterize how PACSIN2 modulates membrane-cytoskeletal interactions and integrin activity in megakaryocytes to govern the formation and organization of the demarcation membrane system and...
The federal Project Grant award of $620,371, provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), will fund research to determine the voltage-sensing domain (VSD) dynamics of cardiac ion channels from the CNBD family, which play a pivotal role in regulating the electrical properties of the heart. The overarching objective is to leverage advanced biophysical techniques, including patch-clamp fluorometry, transition...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) will provide $633,720 to The Washington University to conduct research on protein arginylation and its impact on cardiovascular health and development. The key objectives are to: Develop a chemical proteomics platform to comprehensively identify proteins that undergo arginylation in cardiac cells and tissues. This will involve mapping the "arginylome" and...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $434,658 to Oakland University to conduct research on the intracellular function of the platelet protein TREM-like transcript-1 (TLT-1). The research aims to characterize the phosphorylation sites of TLT-1 and decipher the intracellular cues that regulate its trafficking in platelets. The...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $445,708 to Brigham & Women's Hospital Inc. over a 3-year period starting May 1, 2025. The award will fund research to define the impact of platelet ABO(H) blood group antigens on hemostasis and thrombosis. The key objectives are to: 1) Quantify the binding kinetics of von Willebrand factor to platelets of different ABO blood types, and...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $149,804 to The University of Texas Southwestern Medical Center to study the native in situ structure of myofibrils within intact human cardiomyocytes derived from induced pluripotent stem cells. The research aims to use advanced cryo-electron tomography techniques to directly observe conformational alterations in cardiac b-myosin due to...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $779,952 to Thomas Jefferson University's Sidney Kimmel Medical College to conduct research on the role of platelets in remote organ injury and infection after ischemic stroke. The key objectives are to: 1) elucidate how activated platelets contribute to remote organ injury and infection following ischemic stroke/reperfusion; 2) determine which platelet components...